Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Completed
Children's Cancer Group
Phase 2
1995-04-01
Phase II trial to study the effectiveness of combination chemotherapy in treating patients
with newly diagnosed metastatic Ewing's sarcoma or primitive neuroectodermal tumor. Drugs
used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Combining more than one drug may kill more tumor cells.
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Completed
National Cancer Institute (NCI)
Phase 2
1995-04-01
Phase II trial to study the effectiveness of combination chemotherapy in treating patients
with newly diagnosed metastatic Ewing's sarcoma or primitive neuroectodermal tumor. Drugs
used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Combining more than one drug may kill more tumor cells.
Amifostine in Treating Patients With Myelodysplastic Syndrome
Completed
National Cancer Institute (NCI)
Phase 2
1997-06-05
RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
myelodysplastic syndrome.
Amifostine in Treating Patients With Myelodysplastic Syndrome
Completed
M.D. Anderson Cancer Center
Phase 2
1997-06-05
RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
myelodysplastic syndrome.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
